Sinopharm
Zhang Yuwei—Xinhua/Getty Images
Company Information
As of 8/3/2022
Country
China
Headquarters
Beijing
Industry
Pharmaceuticals
CEO
Liu Jingzhen
Website
Company Type
Private
Ticker
-
Revenues ($M)
$108,779.3
Profits ($M)
$12,164.8
Market Value ($M)
-
Employees
201,092
Government owned 50% or more.
Key Financials (Last Fiscal Year)
($ Millions)
% change
Revenues ($M)
$108,779.3
40.8%
Profits ($M)
$12,164.8
866.4%
Assets ($M)
$88,792.9
-
Total Stockholder Equity ($M)
$23,818.6
-
Profit Ratios
Profit as % of Revenues
11.2%
Profits as % of Assets
13.7%
Profits as % of Stockholder Equity
51.1%
Lists ranking Sinopharm
Latest news for Sinopharm
- Finance
The world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021August 15, 2022, 10:15 PM UTC - Health
A Sinopharm booster generates ‘significantly lower’ levels of antibodies against Omicron, according to a new studyDecember 21, 2021, 3:47 AM UTC - Health
J&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: studyDecember 17, 2021, 12:53 PM UTC - Health
Pfizer’s COVID-19 vaccine generated the strongest immune response in study of 4 jabsNovember 15, 2021, 9:10 AM UTC
